Literature DB >> 23641047

Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis.

Paul J Moberg1, Vidyulata Kamath, Dana M Marchetto, Monica E Calkins, Richard L Doty, Chang-Gyu Hahn, Karin E Borgmann-Winter, Christian G Kohler, Raquel E Gur, Bruce I Turetsky.   

Abstract

BACKGROUND: Previous research has provided compelling support for olfactory dysfunction in schizophrenia patients, their first-degree relatives, and youth at-risk for psychosis. A previous meta-analysis revealed large effect sizes across olfactory tasks but was limited to 2 olfactory tasks and did not examine moderator variables. Thus, the current meta-analysis was undertaken to incorporate additional studies, risk cohorts, olfactory test domains, and moderator variable analyses.
METHOD: A meta-analysis was conducted on 67 publications examining olfactory function in schizophrenia patients and 15 publications examining olfactory functioning in youth at-risk for psychosis, first-degree relatives of schizophrenia patients, and individuals with schizotypy.
RESULTS: Results revealed medium-to-large olfactory deficits in schizophrenia patients though significant heterogeneity was evident. Several variables moderated overall study effects. At-risk youths similarly demonstrated medium-to-large effect sizes, whereas first-degree relatives and individuals with schizotypy showed small effects.
CONCLUSIONS: Findings suggest robust olfactory deficits in schizophrenia and at-risk youths. In schizophrenia, several variables had significant impact on these deficits and warrant consideration in prospective studies. Our findings also indicate that olfactory measures may be a useful marker of schizophrenia risk status.

Entities:  

Keywords:  olfaction; psychosis; schizophrenia prodrome; schizotypy; smell

Mesh:

Year:  2013        PMID: 23641047      PMCID: PMC3885295          DOI: 10.1093/schbul/sbt049

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  47 in total

1.  The positive and negative syndrome scale (PANSS) for schizophrenia.

Authors:  S R Kay; A Fiszbein; L A Opler
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

2.  Odor identification, eye tracking and deficit syndrome schizophrenia.

Authors:  Dolores Malaspina; Eliza Coleman; Raymond R Goetz; Jill Harkavy-Friedman; Cheryl Corcoran; Xavier Amador; Scott Yale; Jack M Gorman
Journal:  Biol Psychiatry       Date:  2002-05-15       Impact factor: 13.382

3.  Stability of olfactory identification deficits in neuroleptic-naive patients with first-episode psychosis.

Authors:  W J Brewer; C Pantelis; V Anderson; D Velakoulis; B Singh; D L Copolov; P D McGorry
Journal:  Am J Psychiatry       Date:  2001-01       Impact factor: 18.112

4.  Reduced olfactory bulb volume in patients with schizophrenia.

Authors:  B I Turetsky; P J Moberg; D M Yousem; R L Doty; S E Arnold; R E Gur
Journal:  Am J Psychiatry       Date:  2000-05       Impact factor: 18.112

5.  Impaired olfactory identification in relatives of patients with familial schizophrenia.

Authors:  L C Kopala; K P Good; K Morrison; A S Bassett; M Alda; W G Honer
Journal:  Am J Psychiatry       Date:  2001-08       Impact factor: 18.112

6.  Physiologic impairment of olfactory stimulus processing in schizophrenia.

Authors:  Bruce I Turetsky; Paul J Moberg; Kiana Owzar; Sarah C Johnson; Richard L Doty; Raquel E Gur
Journal:  Biol Psychiatry       Date:  2003-03-01       Impact factor: 13.382

7.  Impairment of odor hedonics in men with schizophrenia.

Authors:  Paul J Moberg; Steven E Arnold; Richard L Doty; Christian Kohler; Stephen Kanes; Steven Seigel; Raquel E Gur; Bruce I Turetsky
Journal:  Am J Psychiatry       Date:  2003-10       Impact factor: 18.112

8.  Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia.

Authors:  Warrick J Brewer; Stephen J Wood; Patrick D McGorry; Shona M Francey; Lisa J Phillips; Alison R Yung; Vicki Anderson; David L Copolov; Bruce Singh; Dennis Velakoulis; Christos Pantelis
Journal:  Am J Psychiatry       Date:  2003-10       Impact factor: 18.112

9.  Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia.

Authors:  Robert C Smith; Abhay Singh; Mauricio Infante; Amaresh Khandat; Angelica Kloos
Journal:  Neuropsychopharmacology       Date:  2002-09       Impact factor: 7.853

10.  Unirhinal olfactory identification deficits in young male patients with schizophrenia and related disorders: association with impaired memory function.

Authors:  Kimberley P Good; Jeffrey S Martzke; Heather I Milliken; William G Honer; Lili C Kopala
Journal:  Schizophr Res       Date:  2002-08-01       Impact factor: 4.939

View more
  39 in total

1.  Smell identification in individuals at clinical high risk for schizophrenia.

Authors:  Kelly Elizabeth Gill; Elizabeth Evans; Jürgen Kayser; Shelly Ben-David; Julie Messinger; Gerard Bruder; Dolores Malaspina; Cheryl Mary Corcoran
Journal:  Psychiatry Res       Date:  2014-07-17       Impact factor: 3.222

2.  Decreased olfactory bulb volumes in patients with fibromyalgia syndrome.

Authors:  Selçuk Sayılır; Neşat Çullu
Journal:  Clin Rheumatol       Date:  2017-07-26       Impact factor: 2.980

Review 3.  Application of olfactory tissue and its neural progenitors to schizophrenia and psychiatric research.

Authors:  Joëlle Lavoie; Akira Sawa; Koko Ishizuka
Journal:  Curr Opin Psychiatry       Date:  2017-05       Impact factor: 4.741

4.  Genome-Wide Association Analysis of the Sense of Smell in U.S. Older Adults: Identification of Novel Risk Loci in African-Americans and European-Americans.

Authors:  Jing Dong; Annah Wyss; Jingyun Yang; T Ryan Price; Aude Nicolas; Michael Nalls; Greg Tranah; Nora Franceschini; Zongli Xu; Claudia Schulte; Alvaro Alonso; Steven R Cummings; Myriam Fornage; Dmitri Zaykin; Leping Li; Xuemei Huang; Stephen Kritchevsky; Yongmei Liu; Thomas Gasser; Robert S Wilson; Philip L De Jager; Andrew B Singleton; Jayant M Pinto; Tamara Harris; Thomas H Mosley; David A Bennett; Stephanie London; Lei Yu; Honglei Chen
Journal:  Mol Neurobiol       Date:  2016-11-23       Impact factor: 5.590

Review 5.  Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.

Authors:  Ellen R Bradley; Joshua D Woolley
Journal:  Neurosci Biobehav Rev       Date:  2017-05-12       Impact factor: 8.989

6.  Oxytocin administration selectively improves olfactory detection thresholds for lyral in patients with schizophrenia.

Authors:  J D Woolley; O Lam; B Chuang; J M Ford; D H Mathalon; S Vinogradov
Journal:  Psychoneuroendocrinology       Date:  2015-01-07       Impact factor: 4.905

7.  Olfactory performance segregates effects of anhedonia and anxiety on social function in patients with schizophrenia.

Authors:  Kristina Cieslak; Julie Walsh-Messinger; Arielle Stanford; Leila Vaez-Azizi; Daniel Antonius; Jill Harkavy-Friedman; Deborah Goetz; Raymond R Goetz; Dolores Malaspina
Journal:  J Psychiatry Neurosci       Date:  2015-11       Impact factor: 6.186

8.  Altered G Protein Coupling in Olfactory Neuroepithelial Cells From Patients With Schizophrenia.

Authors:  Karin E Borgmann-Winter; Hoau-Yan Wang; Rabindranath Ray; Brooke R Willis; Paul J Moberg; Nancy E Rawson; Raquel E Gur; Bruce I Turetsky; Chang-Gyu Hahn
Journal:  Schizophr Bull       Date:  2015-09-15       Impact factor: 9.306

9.  The effect of odor valence on olfactory performance in schizophrenia patients, unaffected relatives and at-risk youth.

Authors:  Vidyulata Kamath; Bruce I Turetsky; Monica E Calkins; Warren B Bilker; Nathan Frishberg; Karin Borgmann-Winter; Christian G Kohler; Catherine G Conroy; Raquel E Gur; Paul J Moberg
Journal:  J Psychiatr Res       Date:  2013-08-14       Impact factor: 4.791

10.  Deletion of collapsin response mediator protein 4 results in abnormal layer thickness and elongation of mitral cell apical dendrites in the neonatal olfactory bulb.

Authors:  Atsuhiro Tsutiya; Hikaru Watanabe; Yui Nakano; Masugi Nishihara; Yoshio Goshima; Ritsuko Ohtani-Kaneko
Journal:  J Anat       Date:  2016-01-06       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.